ARMISTICE CAPITAL LLC 13D and 13G filings for Intensity Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:11 pm Purchase | 2025-06-30 | 13G | Intensity Therapeutics, Inc. INTS | ARMISTICE CAPITAL LLC | 1,237,113 2.560% | 364,566 (+41.78%) | Filing |
| 2025-05-15 3:28 pm Sale | 2025-03-31 | 13G | Intensity Therapeutics, Inc. INTS | ARMISTICE CAPITAL LLC | 872,547 5.750% | -254,321 (-22.57%) | Filing |
| 2025-02-14 5:29 pm Purchase | 2024-12-31 | 13G | Intensity Therapeutics, Inc. INTS | ARMISTICE CAPITAL LLC | 1,126,868 8.130% | 1,126,868 (New Position) | Filing |